Utility of Serum Homocysteine and Lipoprotein(a) in Acute Coronary Syndrome: A Cross-Sectional Study From Western India.

Authors

Bhupender Arya, Pyrus Bhellum, Priyanka Agnihotri, Shyam Lal Mathur

Published in

Cureus. Volume 18. Issue 6. Pages e111472. Epub Jun 25, 2026.

Abstract

Acute coronary syndrome (ACS) remains a major cause of cardiovascular morbidity and mortality in India, with disease onset occurring at younger ages than in Western populations. Serum homocysteine and lipoprotein(a) Lp(a) are recognized non-conventional risk factors whose interrelationship and age-specific relevance in Indian patients with ACS remain poorly defined.
This cross-sectional study was undertaken at Dr. Sampurnanand Medical College and Mathura Das Mathur Hospital, Jodhpur, between January and November 2023. Seventy-five consecutive ACS patients (ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), and unstable angina) were enrolled. Serum homocysteine and Lp(a) were measured by immunoturbidimetry, with Lp(a) ≥30 mg/dL defined as elevated. Receiver operating characteristic (ROC) curve analysis was performed to identify the optimal homocysteine threshold for predicting young-onset ACS.
Younger patients (aged below 40 years) demonstrated significantly higher homocysteine levels than older counterparts (p=0.0009). Elevated Lp(a) was present in nearly half the cohort and was accompanied by significantly higher homocysteine concentrations (p<0.0001). Vitamin B12 deficiency was identified in over half of the patients, potentially contributing to hyperhomocysteinaemia.
Serum homocysteine is markedly elevated in young-onset ACS and correlates positively with Lp(a) levels. These findings suggest that screening for both biomarkers, alongside vitamin B12 assessment, may warrant consideration in the workup of ACS patients, particularly in the Indian population. However, given the cross-sectional, single-center design of the present study and the absence of outcome data, prospective multicenter studies are needed to validate these associations.

PMID:
42502538
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.